Recent events
Recent events tied to this brand in public sources.
Back to profile5 entries
2021
Precigen announces CFO appointment
Precigen announced Harry Thomasian Jr. as its chief financial officer, with the appointment set to take effect on October 18, 2021.
2020
FDA clears Precigen's UltraPorator manufacturing device
Precigen announced that the US Food and Drug Administration cleared UltraPorator as a manufacturing device for its UltraCAR-T manufacturing process.
2020
Precigen reports first-quarter 2020 results
Precigen announced first-quarter 2020 financial results, reporting revenue of $29.8 million and a net loss from continuing operations attributable to Precigen of $29.9 million.
2020
FDA clears Precigen's PRGN-2009 investigational application
Precigen reported that the U.S. FDA cleared the Investigational New Drug application for PRGN-2009 to initiate a Phase 1/2 trial in HPV-positive solid tumors.
2020
MBP Titan completes workforce reduction
Precigen reported that its wholly owned subsidiary MBP Titan significantly reduced its resource requirements through a workforce reduction, as the company focused resources on healthcare programs.